These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26242261)

  • 1. Survivin mRNA-circulating tumor cells are associated with prostate cancer metastasis.
    Wang H; Yang M; Xu J; Zou B; Zhou Q; Bian J; Wang X
    Tumour Biol; 2016 Jan; 37(1):723-7. PubMed ID: 26242261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
    Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
    Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.
    Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W
    Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of osteopontin and survivin in prostate cancer and the clinical significance].
    Yu HB; Han XB; Liang YQ; Liu JG; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1141-3. PubMed ID: 20501415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer.
    Zhang Y; Huang H; Zhou H; Du T; Zeng L; Cao Y; Chen J; Lai Y; Li J; Wang G; Guo Z
    Cancer; 2014 Oct; 120(20):3208-18. PubMed ID: 24925528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of combined measurement of tissue mRNA levels of AMACR and survivin in the diagnosis and risk stratification of patients with suspected prostate cancer.
    Al-Maghrebi M; Kehinde EO; Anim JT; Sheikh M
    Int Urol Nephrol; 2012 Dec; 44(6):1681-9. PubMed ID: 22718029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expressions of survivin and GRIM-19 in prostate cancer].
    Liu YB; Shen WG; Ge H; Gai XD; Lu LL; Zhao XJ
    Zhonghua Nan Ke Xue; 2011 Jan; 17(1):21-6. PubMed ID: 21351527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
    Khan S; Jutzy JM; Valenzuela MM; Turay D; Aspe JR; Ashok A; Mirshahidi S; Mercola D; Lilly MB; Wall NR
    PLoS One; 2012; 7(10):e46737. PubMed ID: 23091600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
    Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
    Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting survivin using a combination of miR‑494 and survivin shRNA has synergistic effects on the suppression of prostate cancer growth.
    Zhu J; Sun C; Wang L; Xu M; Zang Y; Zhou Y; Liu X; Tao W; Xue B; Shan Y; Yang D
    Mol Med Rep; 2016 Feb; 13(2):1602-10. PubMed ID: 26718651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human telomerase reverse transcriptase, Survivin, DD3 and PCGEM1 messenger RNA in archival prostate carcinoma tissue.
    Bialkowska-Hobrzanska H; Driman DK; Fletcher R; Harry V; Razvi H
    Can J Urol; 2006 Feb; 13(1):2967-74. PubMed ID: 16515751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
    Almami A; Hegazy SA; Nabbi A; Alshalalfa M; Salman A; Abou-Ouf H; Riabowol K; Bismar TA
    Tumour Biol; 2016 Jul; 37(7):9731-8. PubMed ID: 26803516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin is a potential mediator of prostate cancer metastasis.
    Zhang M; Coen JJ; Suzuki Y; Siedow MR; Niemierko A; Khor LY; Pollack A; Zhang Y; Zietman AL; Shipley WU; Chakravarti A
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1095-103. PubMed ID: 20231071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
    Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
    Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer.
    He HC; Bi XC; Zheng ZW; Dai QS; Han ZD; Liang YX; Ye YK; Zeng GH; Zhu G; Zhong WD
    Med Oncol; 2009; 26(3):303-8. PubMed ID: 19003546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of pim-1 mRNA in prostate cancer diagnosis.
    He HC; Bi XC; Dai QS; Wang SS; Wei HA; Zhong WD; Liu WH; Jiang FN; Liu LS
    Chin Med J (Engl); 2007 Sep; 120(17):1491-3. PubMed ID: 17908456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of nucleostemin in prostate cancer tissues and its clinical significance].
    Liu RL; Xu Y; Zhang ZH; Wang M; Sun JT; Qi SY; Zhang Y; Li SZ
    Zhonghua Nan Ke Xue; 2008 May; 14(5):418-22. PubMed ID: 18572860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.